Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Jackisch

Showing results (1-10 of 231) with videos related to

Pageof 24
Sort By:
The Oncologist|September 15, 2006
HER-2-positive metastatic breast cancer: optimizing trastuzumab-based therapyChristian Jackisch
Breast Care (Basel, Switzerland)|September 9, 2010
Treatment Options in ErbB2 (HER2)-Overexpressing Breast CancerChristian Jackisch
Krankenpflege Journal|August 22, 2003
[How to manage patients who ask? Breast cancer]Christian Jackisch
The Lancet. Oncology|August 13, 2019
Overcoming endocrine resistance in neoadjuvant endocrine therapy for early breast cancerChristian Jackisch
Krankenpflege Journal|September 21, 2005
[Healing in sight?]Christian Jackisch
Onkologie|February 1, 2007
Optimal treatment strategies in hormone-responsive early breast cancer: the role of aromatase inhibitorsMichael Untch, Christian Jackisch
Therapeutics and Clinical Risk Management|April 2, 2009
Exemestane in early breast cancer: a reviewMichael Untch, Christian Jackisch
Expert Review of Anticancer Therapy|February 24, 2011
Comparing guidelines for adjuvant endocrine therapy in postmenopausal women with breast cancer: a coming of ageSunil Verma, Christian Jackisch
Expert Review of Anticancer Therapy|March 1, 2014
Evaluating the role of nab-paclitaxel (Abraxane) in women with aggressive metastatic breast cancerEva Ciruelos, Christian Jackisch
Breast Care (Basel, Switzerland)|September 18, 2010
Systemic Therapy for Women with ErbB2-Positive Breast Cancer: New Options, New ChallengesChristian Jackisch, Michael Untch
Pageof 24

Showing results (1-10 of 231) with videos related to

Sort By:
Pageof 24
The Oncologist|September 15, 2006
HER-2-positive metastatic breast cancer: optimizing trastuzumab-based therapyChristian Jackisch
Breast Care (Basel, Switzerland)|September 9, 2010
Treatment Options in ErbB2 (HER2)-Overexpressing Breast CancerChristian Jackisch
Krankenpflege Journal|August 22, 2003
[How to manage patients who ask? Breast cancer]Christian Jackisch
The Lancet. Oncology|August 13, 2019
Overcoming endocrine resistance in neoadjuvant endocrine therapy for early breast cancerChristian Jackisch
Krankenpflege Journal|September 21, 2005
[Healing in sight?]Christian Jackisch
Onkologie|February 1, 2007
Optimal treatment strategies in hormone-responsive early breast cancer: the role of aromatase inhibitorsMichael Untch, Christian Jackisch
Therapeutics and Clinical Risk Management|April 2, 2009
Exemestane in early breast cancer: a reviewMichael Untch, Christian Jackisch
Expert Review of Anticancer Therapy|February 24, 2011
Comparing guidelines for adjuvant endocrine therapy in postmenopausal women with breast cancer: a coming of ageSunil Verma, Christian Jackisch
Expert Review of Anticancer Therapy|March 1, 2014
Evaluating the role of nab-paclitaxel (Abraxane) in women with aggressive metastatic breast cancerEva Ciruelos, Christian Jackisch
Breast Care (Basel, Switzerland)|September 18, 2010
Systemic Therapy for Women with ErbB2-Positive Breast Cancer: New Options, New ChallengesChristian Jackisch, Michael Untch
Pageof 24